New Brochure Helps Patients Understand Treatments for Bladder Cancer
Posted on: Tuesday, 22 November 2005, 12:00 CST
FAIRFAX, Va., Nov. 21 /U.S. Newswire/ -- To help patients and their families understand how radiation therapy works in conjunction with other treatments to cure bladder cancer, the American Society for Therapeutic Radiology and Oncology (ASTRO) has developed a brochure, Radiation Therapy for Bladder Cancer, that patients can use to talk with their healthcare providers when contemplating radiation therapy as part of their treatment. The brochure also helps patients find support groups and information on clinical trials.
"Radiation therapy is a treatment option that patients with bladder cancer should consider," said Gregory Patton, M.D., vice- chair of ASTRO's Communications Committee and a radiation oncologist at Northwest Cancer Specialists in Portland, Ore. "I hope this brochure will help people with bladder cancer better understand their treatment options so they can make the best, most informed decision on their care."
Radiation therapy works within cancer cells by damaging their ability to multiply; when the cancerous cells die, the body naturally eliminates them. External beam radiation therapy is the most common type of radiation used to combat bladder cancer and is often used in combination with chemotherapy and surgery. Patients receive radiation therapy through a series of daily outpatient treatments that last around a half hour each day for five to seven weeks. As with any treatment option, radiation therapy has some temporary side effects that may include skin irritation, nausea, bladder irritation with increased frequency of urination, abdominal cramping and fatigue.
The American Cancer Society estimates that more than 63,000 new cases of bladder cancer will be diagnosed in the United States this year. Fortunately, with modern treatments and early detection, the five-year survival rate for all types of bladder cancer is 82 percent. Some specific risk factors for bladder cancer include smoking tobacco products, working in jobs where there is possible chemical exposure, and chronic bladder inflammation such as urinary tract infections, bladder stones and kidney stones.
Patients and patient advocacy organizations can request free copies of the brochure by calling 1-800-962-7876 or e-mailing nickl(At)astro.org. The brochure can also be viewed online at http:/ /www.rtanswers.org.
---
ASTRO is the largest radiation oncology society in the world, with more than 8,000 members who specialize in treating patients with radiation therapies. As a leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving socioeconomic healthcare environment.
http://www.usnewswire.com
Source: U.S. Newswire
Related Articles
- Intense bladder cancer therapy not better
- Bioniche Granted Fast Track Status for Bladder Cancer Therapy
- Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
- Bacilligen, Inc. Files Patent Applications on BVS Recombinant Capsid Vector Technology and rMB Improved Bladder Cancer Therapy
- Loma Linda University to Dedicate Proton Treatment Center to Cancer Therapy Pioneer James M. Slater, M.D.
- Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
- Targeted Cancer Therapies Expand the Oncology Market By Increasing Age Limit for Treatment
- Bioniche Bladder Cancer Drug Fast Tracked By FDA
- CLINICAL REVIEW: The Management of Bladder Cancer
- Spectrum Pharmaceuticals Completes Enrollment in EOquin(TM) Multi-Center Phase 2 Trial for Refractory Superficial Bladder Cancer
 |
 |
User Comments (0)
RSS Feeds